Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.39 |
| ▸ | FLT3 | P36888 | 2/20 | 0.36 |
| ▸ | TYRO3 | Q06418 | 2/20 | 0.36 |
| ▸ | MERTK | Q12866 | 2/20 | 0.36 |
| ▸ | GAS6 | Q14393 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | GBA1 | P04062 | 1/20 | 0.32 |
| ▸ | CDK1 | P06493 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL39771 | 0.83 | FLT3 (0.31) | FLT3TYRO3MERTKGAS6 | |
| SCHEMBL4593354 | 0.76 | FLT3 (0.31) | FLT3TYRO3MERTKGAS6 | |
| SCHEMBL5650386 | 0.71 | — | — | |
| SCHEMBL6725345 | 0.67 | — | — | |
| SCHEMBL2783134 | 0.65 | SLC29A1 (0.73) | SLC29A1FLT3TYRO3MERTKGAS6 | |
| SCHEMBL9913748 | 0.65 | SLC29A1 (0.73) | SLC29A1FLT3TYRO3MERTKGAS6 | |
| SCHEMBL870341 | 0.61 | GNAI3 (0.37) | FLT3TYRO3MERTKGAS6GBA1 | |
| SCHEMBL8386905 | 0.60 | FUCA1 (0.37) | GBA1 | |
| SCHEMBL13531453 | 0.60 | FLT3 (0.39) | SLC29A1FLT3TYRO3MERTKGAS6 | |
| SCHEMBL13246429 | 0.59 | FLT3 (0.36) | FLT3TYRO3MERTKGAS6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6365652-B2 | AMIDO OR CARBAMATE SUBSTITUTED TRISARYL-1,3,5-TRIAZINES USED AS ACTINIC RADIATION STABILIZER BY INCORPORATING THE ABOVE COMPOUND INTO THE ORGANIC POLYMER BY CHEMICAL BONDING | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-04-02 | — | — | US | disclosed |
| US-20010037022-A1 | Trisaryl-1,3,5-triazine ultraviolet light absorbers | GUPTA RAM BABOO (US) | 2001-11-01 | — | — | US | disclosed |
| US-6265576-B1 | STABILIZERS | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010037022-A1 | Trisaryl-1,3,5-triazine ultraviolet light absorbers | CRYZ, ERCC5, TELO2 | SLC29A1 2162/4885FLT3 2022/4885TYRO3 332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.